Clinical potential for vitamin D as a neoadjuvant for photodynamic therapy of nonmelanoma skin cancer

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 9308, Issue , 2015, Pages

  Maytin, Edward V ^a,b,c,d   Anand, Sanjay ^a,b   Rollakanti, Kishore ^a,d  

^a Dept of Dermatology ^*  (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Cleveland State University   (United States)

Author keywords

differentiation; fluorescence; Photodynamic therapy; protoporphyrin IX; skin cancer; vitamin D

Indexed keywords

DERMATOLOGY; DIFFERENTIATION (CALCULUS); DISEASES; FLUORESCENCE; IONIZING RADIATION; MAMMALS; TUMORS; VITAMINS;

BASAL CELL CARCINOMA; EFFECTIVE THERAPY; NONMELANOMA SKIN; PROTOPORPHYRIN IX; SKIN CANCERS; SQUAMOUS CELL CARCINOMA; SURGICAL EXCISION; VITAMIN-D;

PHOTODYNAMIC THERAPY;

EID: 84926435811     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.2077234     Document Type: Conference Paper

References (26)

1. Hasan, T., Ortel, B., Solban, N. and Pogue, B.W., "Photodynamic therapy of cancer, " in[Cancer Medicine], 7th edition, D. Kufe et al., eds, BC Decker, Inc., Hamilton, Ontario, 537-548 (2006).
2. Campbell, S.M., Tyrrell, J., Marshall, R. and Curnow, A., "Effect of MAL-photodynamic therapy on hypertrophic scarring, " Photodiagnosis Photodyn. Ther. 7(3), 183-8 (2010).
3. Nie, Z., Bayat, A., Behzad, F. and Rhodes, L.E., "Positive response of a recurrent keloid scar to topical methyl aminolevulinate-photodynamic therapy, " Photodermatol. Photoimmunol. Photomed. 26(6), 330-2 (2010).
4. Donaldson, M.R. and Coldiron, B.M., "No end in sight: the skin cancer epidemic continues, " Semin. Cutan. Med. Surg. 30(1), 3-5 (2011).
5. American Cancer Society. Statistics. Available at: http://www.cancer.org/docroot/stt/stt-0.asp (2008).
6. Bickers, D.R., Lim, H.W., Margolis, D., Weinstock, M.A., Goodman, C., Faulkner, E., et al., "The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology, " J. Am. Acad. Dermatol. 55(3), 490-500 (2006).
7. Neidecker, M.V., Davis-Ajami, M.L., Balkrishnan, R. and Feldman, S.R., "Pharmacoeconomic considerations in treating actinic keratosis, " Pharmacoeconomics. 27(6), 451-64 (2009).
8. Braathen, L.R., Szeimies, R.M., Basset-Seguin, N., Bissonnette, R., Foley, P., Pariser, D., et al., "Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005, " J. Am. Acad. Dermatol. 56(1), 125-43 (2007).
9. de Vijlder, H.C., Sterenborg, H.J., Neumann, H.A., Robinson, D.J. and de Haas, E.R., "Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial, " Acta Derm. Venereol. 92(6), 641-7 (2012).
10. Foley, P., Freeman, M., Menter, A., Siller, G., El-Azhary, R.A., Gebauer, K., et al., "Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies, " Int. J. Dermatol. 48(11), 1236-45 (2009).
11. Chren, M.M., Linos, E., Torres, J.S., Stuart, S.E., Parvataneni, R. and Boscardin, W.J., "Tumor Recurrence 5 Years after Treatment of Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma, " J. Invest. Dermatol. 133(5), 1188-96 (2012).
12. Tom, W.L., Hurley, M.Y., Oliver, D.S., Shah, M.R. and Bree, A.F., "Features of basal cell carcinomas in basal cell nevus syndrome, " Am. J. Med. Genet A. 155A(9), 2098-2104 (2011).
13. Mang, T.S., Allison, R., Hewson, G., Snider, W. and Moskowitz, R., "A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer, " Cancer J. Sc. Am. 4(6), 378-84 (1998).
14. Cuenca, R.E., Allison, R.R., Sibata, C. and Downie, G.H., "Breast cancer with chest wall progression: treatment with photodynamic therapy, " Ann. Surg. Oncol. 11(3), 322-7 (2004).
15. Anand, S., Hasan, T. and Maytin, E.V., "Mechanism of differentiation-enhanced photodynamic therapy for cancer: upregulation of coproporphyrinogen oxidase by C/EBP transcription factors, " Mol. Cancer Ther. 12(8), 1638-50 (2013).
16. Anand, S., Honari, G., Hasan, T., Elson, P. and Maytin, E.V., "Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo, " Clin. Cancer Res. 15(10), 3333-43 (2009).
17. Anand, S., Honari, G., Paliwal, A., T., H. and EV., M., "Enhancement of tumor responsiveness to aminolevulinate-photodynamic therapy (ALA-PDT) using differentiation-promoting agents in mouse models of skin carcinoma; Photodynamic Therapy: Back to the Future, " Proc. SPIE 73804, B1-B7 (2009).
18. Anand, S., Ortel, B.J., Pereira, S.P., Hasan, T. and Maytin, E.V., "Biomodulatory approaches to photodynamic therapy for solid tumors, " Cancer Lett. 326(1), 8-16 (2012).
19. Anand, S., Wilson, C., Hasan, T. and Maytin, E.V., "Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy, " Cancer Res. 71(18), 6040-50 (2011).
20. Maytin, E., Anand, S., Wilson, C. and Iyer, K., "5-Fluorouracil as an enhancer of aminolevulinate-based photodynamic therapy for skin cancer: New use for a venerable agent?, " Proc. SPIE 7886, OK1-OK8 (2011).
21. Sato, N., Moore, B.W., Keevey, S., Drazba, J.A., Hasan, T. and Maytin, E.V., "Vitamin D enhances ALAinduced protoporphyrin IX production and photodynamic cell death in 3-D organotypic cultures of keratinocytes, " J. Invest. Dermatol. 127(4), 925-34 (2007).
22. Maytin, E.V., Honari, G., Khachemoune, A., Taylor, C.R., Ortel, B., Pogue, B.W., et al., "Vitamin D Combined with Aminolevulinate (ALA)-Mediated Photodynamic Therapy (PDT) for Human Psoriasis: A Proof-of-Principle Study, " Israel J. Chem. 52(8), 767-775 (2012).
23. Horst, R.L., Reinhardt, T.A. and Reddy, G.S., "Vitamin D Metabolism"[Vitamin D], Feldman, Pike, and Glorieux, eds, Elsevier: Boston, 15-36 (2005).
24. Tang, J.Y., Fu, T., Lau, C., Oh, D.H., Bikle, D.D. and Asgari, M.M., "Vitamin D in cutaneous carcinogenesis: part II, " J. Am. Acad. Dermatol. 67(5), 817 e1-11 (2012).
25. Tang, J.Y., Fu, T., Lau, C., Oh, D.H., Bikle, D.D. and Asgari, M.M., "Vitamin D in cutaneous carcinogenesis: part I, " J. Am. Acad. Dermatol. 67(5), 803 e1-12 (2012).
26. Tang, T., Tang, J.Y., Li, D., Reich, M., Callahan, C.A., Fu, L., et al., "Targeting superficial or nodular Basal cell carcinoma with topically formulated small molecule inhibitor of smoothened, " Clin. Cancer Res. 17(10), 3378-87 (2011).